Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Oncogene|May 1, 1990
The leucine zipper domain of avian cMyc is required for transformation and autoregulationD H Crouch, C Lang, D A GillespieJournal of Hepatology|May 1, 1989
Hepatic vein webs and resistant ascites. Diagnosis, management and implicationsC R Vickers, R J West, S G Hubscher, et al.Cell|May 1, 1985
Rearrangements of viral and cellular DNA are often associated with expression of Rous sarcoma virus in rat cellsD A Gillespie, K A Hart, J A WykeExperimental Cell Research|January 7, 2000
Inhibition of the terminal stages of adipocyte differentiation by cMycV J Heath, D A Gillespie, D H CrouchNucleic Acids Research|July 10, 1982
The changes in proviral chromatin that accompany morphological variation in avian sarcoma virus-infected rat cellsD J Chiswell, D A Gillespie, J A WykeOncogene|November 1, 1991
Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: correlation with oncogenic activation and deregulated transactivation activity of v-JunE J Black, A J Street, D A GillespieBiochemical and Biophysical Research Communications|March 10, 2000
Inhibition of adipocyte differentiation by cMyc is not accompanied by alterations in cell cycle controlV J Heath, D A Gillespie, D H CrouchThe Medical Journal of Australia|November 11, 1985
Cyclosporin, a new treatment for autoimmune chronic active hepatitisS P Mistilis, C R Vickers, M H Darroch, et al.Oncogene|June 6, 1996
The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transductionA Kilbey, E J Black, M Unlu, et al.Oncogene|December 1, 1994
c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformationS A La Rocca, D H Crouch, D A GillespiePageof 5